Bristol-Myers Squibb Company (BMY) · page 6 of 16
The chart highlights the 'patent cliff' risk, specifically focusing on the concentration of revenue loss in 2026.
Shareholder letter · villain_critique · diagnose_problem · overcrowded density
Slide locked Sign in to view
Slide schematic 7/9
callout 0/1 chart 1/1 metric 0/1 paragraph 4/4 source-note 1/1 title 1/1
2 without position callout 1 · metric 1
calloutmetric · primary
Components 9
callout bar-stacked primary paragraph paragraph paragraph paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.